Does the knowledge of the human immunodeficiency virus serostatus influence the clinical diagnostic proficiency of Kaposi's sarcoma?

References

• Pyakurel P, Pak F, Mwakigonja AR, et al. Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. Int J Cancer. 2006; 119(6): 1262–1267.
   PubMed Web of Science ®Google Scholar
• Chang Y Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266(5192): 1865–1869.
   PubMed Web of Science ®Google Scholar
• Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA. 1999; 96(8): 4546–4551.
   PubMed Web of Science ®Google Scholar
• Kirkham N. Tumors and cysts of the epidermis. Lever's histopathology of the skin. 10th ed. In: Elder DE, editor. Philadelphia: Lippincott Williams & Wilkins, 2009; p. 795.
   Google Scholar
• Calonje E. Vascular tumors: tumors and tumor-like conditions of blood vessels and lymphatics. Lever's histopathology of the skin. 10th ed. In: Elder DE, editor Philadelphia: Lippincott Williams & Wilkins, 2009; p. 1015.
   Google Scholar
• Aldenhoven M, Barlo NP, Sanders CJG. Therapeutic strategies for epidemic Kaposi's sarcoma. Int J STD AIDS. 2006; 17(9): 571–578.
   PubMed Web of Science ®Google Scholar
• Mbulaiteye SM, Katabira ET, Wabinga H, et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer. 2006; 118(4): 985–990.
   PubMed Web of Science ®Google Scholar
• Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006; 118(12): 3030–3044.
   PubMed Web of Science ®Google Scholar
• Mwanda OW, Fu P, Collea R, Whalen C, Remick SC. Kaposi's sarcoma in patients with and without human immunodeficiency virus infection in a tertiary referral centre in Kenya. J Trop Med Parasit. 2005; 99(1): 81–91.
   PubMed Web of Science ®Google Scholar
• Chu KM, Mahlangeni G, Swannet S, et al. Aids-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa. J Int AIDS Soc. 2010; 13(1): 23–27.
   PubMed Web of Science ®Google Scholar
• Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000; 342(1): 1027–1038.
   PubMed Web of Science ®Google Scholar
• Nasti G, Talamini R, Antinori A, et al. AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group staging system in the HAART era: the Italian Cooperative Group on AIDS and tumors and the Italian cohort of patients naïve from antiretrovirals. J Clin Oncol. 2003; 21(15): 2876–2882.
   PubMed Web of Science ®Google Scholar
• Cai Q, Verma SC, Liu J, Robertson ES. Molecular biology of Kaposi's sarcoma herpesvirus and related oncogenesis. Adv Virus Res. 2010; 78: 87–142.
   PubMed Web of Science ®Google Scholar
• Dedicoat M, Vaithhilingum M, Newton R. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings. [Cochrane Review]. In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
   Google Scholar
• Sissolak G, Mayaud P. AIDS-related Kaposi's sarcoma: epidemiological diagnostic, treatment and control aspects in sub-Saharan Africa. Trop Med Int Health. 2005; 10(10): 981–992.
   PubMed Web of Science ®Google Scholar
• Mosam A, Aboobaker J, Shaik F. Kaposi's sarcoma in sub-Saharan Africa: a current perspective. Curr Opin Infect Dis. 2010; 23(2): 119–123.
   PubMed Web of Science ®Google Scholar
• Stebbing J, Sanitt A, Nelson M, et al. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy. Lancet. 2006; 367(9521): 1495–1502.
   PubMed Web of Science ®Google Scholar
• El Amari EB, Toutous-Trellu L, Gayet-Ageron A, et al. Predicting the evolution of Kaposi's sarcoma in the highly active antiretroviral era. AIDS. 2008; 22(9): 1019–1028.
   PubMed Web of Science ®Google Scholar
• Ziegler J, Newton R, Bourboulia D, et al. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda. Int J Cancer. 2003; 103(2): 223–240.
   Web of Science ®Google Scholar
• Mohammed AZ, Nwana EJ, Manasseh AN. Changing patterns of Kaposi's sarcoma in Nigerians. Trop Doc. 2005; 35(3): 168–169.
   PubMed Web of Science ®Google Scholar
• Wamburu G, Masenga EJ, Moshi EZ, et al. HIV-associated and non-HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 prevalence. Eur J Dermatol. 2006; 16(6): 677–682.
   PubMed Web of Science ®Google Scholar
• Kagu MB, Nggada HA, Garandawa HI, et al. AIDS-associated Kaposi's sarcoma in Northeastern Nigeria. Singapore Med J. 2006; 47(12): 1069–1074.
   PubMedGoogle Scholar
• Mosam A, Hurkchand HP, Cassol E, et al. Characteristics of HIV-1 associated Kaposi's sarcoma among women and men in South Africa. Int J STD AIDS. 2008; 19(6): 400–405.
   PubMed Web of Science ®Google Scholar
• Von Pressentin KB, Conradie HH, Mash R. A medical audit of the management of cryptococcal meningitis in HIV-positive patients in the Cape Winelands (East) district, Western Cape. S Afr Fam Pract. 2012; 54(3): 339–346.
   Google Scholar